To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
Status:
Terminated
Trial end date:
2017-07-15
Target enrollment:
Participant gender:
Summary
All consecutive ACLF (Acute on Chronic Liver failure) patients presenting to the institute of
liver and biliary sciences, irrespective of the etiology , who have survived the acute phase
(i.e. 90 days of onset of the acute on chronic liver failure) and who are willing to
participate in the study would be enrolled. After performing baseline biochemical tests,
patients will undergo transjugular liver biopsy (TJLB), HVPG (Hepatic Venous Pressure
Gradient), Circulating CD34 cells, Bone marrow aspiration and biopsy (Histopathological and
immunohistochemical examination will be done).